Sofinnova chairman discusses entrepreneurial culture change for biotech startups

April 13, 2017 Christoph Graener

Antoine Papiernik is the chairman of Paris-based Sofinnova Partners, a venture capital firm that invests in startups and spinout biotech companies primarily in Europe. He spoke with Luke Timmerman, the founder and editor of Timmerman Report, a biotech industry newsletter, at BIO-Europe Spring in Barcelona about some of the cultural challenges facing startups in Europe.

Interviewer: Luke Timmerman – Founder and Editor, Timmerman Report
Interviewee: Antoine Papiernik – Chairman, Sofinnova Partners

Previous Article
Noxxon CEO discusses partners and cancer combinations

Aram Mangasarian, CEO of Noxxon Pharma, a biotech company focused on cancer therapies targeting the tumor m...

Next Article
Chronic constipation device impresses judges in startup competition

usMIMA CEO and co-founder Markus Wilhelms talks to Scrip about the company’s medical device, MowoOT, which ...